|
|
Post by sla55 on Feb 1, 2017 17:04:45 GMT -5
|
|
|
|
Post by mnkdnewb on Feb 1, 2017 17:07:46 GMT -5
Called it 4 days ago / 6 months ago |
|
|
|
Post by jonny80s on Feb 1, 2017 17:27:09 GMT -5
Here comes the sell off. Fortunately in terms of percent lose for most of us it is not a big deal. 85% lost vs 95% lost, who cares?
|
|
|
|
Post by wmdhunt on Feb 1, 2017 17:32:49 GMT -5
Well, if I wind up with fewer shares, maybe I won't look quite so stupid... lol
|
|
|
|
Post by winstonsmith on Feb 1, 2017 17:34:40 GMT -5
Upsetting to say the least.
|
|
|
|
Post by esstan2001 on Feb 1, 2017 17:39:12 GMT -5
look- at least they are covered now. This is insurance. Yes there is a fair chance they will need to take out that insurance.
But at least they have some time to either nail down a deal or grow scripts before they hit the point where they are forced to pull this lever.
It was the most sensible thing for them to do at this stage.
Now Mike better get scripts, or Ray better get Epi or some trials started.
|
|
|
|
Post by LosingMyBullishness on Feb 1, 2017 17:40:10 GMT -5
To winston: Why? A reverse split is only a change in share count not in value.
|
|
|
|
Post by therealcd on Feb 1, 2017 17:40:20 GMT -5
WoW first of all what a cute pic. kidding. Yes, I kind of wondered myself what actually this call was going to be about. I was right, when Kevinmik brought it up "why aren't you being more Transparent" -- then there we have it. An absolutely meaningless call IMO that the only thing learned was an R/S. Mike didn't provide much of anything that I noted other than "They are fine tuning the model." The model meaning what exactly. |
|
|
|
Post by james on Feb 1, 2017 17:45:20 GMT -5
To winston: Why? A reverse split is only a change in share count not in value. The split is only step one. Step two is the dilution later this year to raise another $50M+ to keep operations running. This is the obvious and unavoidable path. |
|
|
|
Post by madog365 on Feb 1, 2017 17:49:04 GMT -5
I'll be the first to admit i expected a much better call in regards to a different path to get the company above a dollar. Anything to avoid delisting is right though and unfortunately the sales haven't picked up enough to justify a dollar share price. I'm hoping we can ramp this salesforce immediately.
|
|
|
|
Post by therealcd on Feb 1, 2017 17:53:30 GMT -5
I'll be the first to admit i expected a much better call in regards to a different path to get the company above a dollar. Anything to avoid delisting is right though and unfortunately the sales haven't picked up enough to justify a dollar share price. I'm hoping we can ramp this salesforce immediately. Love ya maddog. Speaking of maddog go ahead shut off the reddit if you want. We don't need it now. If you put in a good word for me though it'd be appreciated. They are still 'warning me' here. Note to admin: I will follow the rules going forward. Or, you can chop off my head.  |
|
|
|
Post by sophie on Feb 1, 2017 17:55:17 GMT -5
look- at least they are covered now. This is insurance. Yes there is a fair chance they will need to take out that insurance. But at least they have some time to either nail down a deal or grow scripts before they hit the point where they are forced to pull this lever. It was the most sensible thing for them to do at this stage. Now Mike better get scripts, or Ray better get Epi or some trials started. $2 billion and over a decade later still under 300 scripts/week. Afrezza has been ours for 6 months. Statistically negligible results in that time frame on the scale we need. How much time do they need? How much more money? Is that money even available? They are in over their heads and it's never been more clear than today. They may have a plan, but it doesn't appear that plan has been working. I'm not confident they'll figure it out. It's important to get packaging correct. It's important to get payors on board. We've increased coverage but have seen no growth in script counts. The biggest issue isn't with coverage. I don't think the biggest issue is packaging, either, although I guess we'll see. In my eyes the biggest issue is either getting an audience with a physician to educate them on Afrezza, or pure apathy from a prescriber's standpoint if that meeting ever occurred. This thing was bungled from the get go, but you only get one chance to make a first impression. I hope for our sakes there are still enough doctors out there who have not had a bad experience with Afrezza to recover. |
|
|
|
Post by u1682002 on Feb 1, 2017 17:58:38 GMT -5
To winston: Why? A reverse split is only a change in share count not in value. The split is only step one. Step two is the dilution later this year to raise another $50M+ to keep operations running. This is the obvious and unavoidable path. James, do you know any cases that an investors got rewarded in the end after such a R/S? Thanks |
|
|
|
Post by papanigon on Feb 1, 2017 19:12:08 GMT -5
So the PPS takes care of itself by doing a R/S. Nice call Matt.
|
|
|
|
Post by dg1111 on Feb 1, 2017 19:20:37 GMT -5
You can put me in the boat that thought we were going to get positive news on this call. That said, a reverse split had to have been pretty well priced in at this point. We had been under $1 for about 4 months, so either Matt was going to pull a rabbit out of a hat or a reverse split was going to happen. The price may drop some, but I don't think it will be as drastic as others are predicting.
Even if we signed a partnership for either Epi or international expansion of Afrezza that gave us, say $25m up front (which was doubtful), would that have put us over $1?
It's time for the new sales staff to start selling Afrezza.
|
|
